Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Post by jmthibson Jul 11, 2020 11:02am
302 Views
Post# 31255301

SONA vs. QDEL by the numbers - looking for feedback

SONA vs. QDEL by the numbers - looking for feedbackI wanted to do my own DD to see how QDEL developments has impacted it's market cap rather than try and make SP predictions. Please feel free to comment or provide insights I've missed.

-Prior to the EUA of the LYRA test for COVID-19 (March 16th), they had a 3.1B cap
-March 17th close was 93.64$ or a 3.93B market cap

-May 8th, on no other news, market cap is 6.63B (based on SP of 158.60$)
-EUA granted for the POC test after close on May 8th, and market cap goes to 8.73B on Monday, May 11th. (based on SP of 208$)

-As of writing this, market cap is 10.4B (all numbers USD$ of course) based on 200M$ in revenues for Q2. This gives us a P/E ration of about 120, or Price/Sales of 18. I've not been able to find any details about sales estimates for POC tests, or pre-orders...If anyone has any, please let me know.

All this to say, the value of QDEL has gone up by 7B in the last 4 ish months, with no sales. So just imagine SONA with a more efficient, more accurate test, and "10's of millions of pre-orders" and what the possibilities for us might be.
<< Previous
Bullboard Posts
Next >>